
Globally, 331 million women and 317 million men had hypertension in 1990, compared with 626 million women and 652 million men in 2019.
Connor Iapoce is the assistant managing editor for HCPLive, after joining the MJH Life Sciences team in April 2021. He graduated from The College of New Jersey with a degree in Journalism and Professional Writing. He enjoys listening to records, going to the movies, and playing with his cat, Squish. You can reach him at [email protected].

Globally, 331 million women and 317 million men had hypertension in 1990, compared with 626 million women and 652 million men in 2019.

The updated USPSTF recommends screening for prediabetes and type 2 diabetes in adults aged 35 - 75 years with conditions including overweight or obesity.

The updated transcatheter aortic valve replacement system incorporates a supra-annular valve design, with a redesigned catheter tip and 4 valve sizes.

A 0.063 mg dose had a probability of 94% to be ≥95% effective, despite being 4- to 10- times lower than common dosage levels.

Pictorial data on carotid intima-media thickness and presence of carotid plaques can improve prescription of lipid-lowering drugs.

Study shows single-session pain relief class noninferior to 8-session cognitive behavioral therapy for pain catastrophizing, pain intensity, and pain interference.

All NOACs had a lower risk of stroke or SE compared to warfarin, including apixaban, dabigatran, and rivaroxaban.

Data show 15% of authors in this analysis reported financial associations with trial sponsors in invasive cardiovascular intervention studies.

Most common factor for hospitalizations of T2D include cardiac disorder, infections and infestations, and nervous system disorders.

In part 2 of an interview with HCPLive, Dr. Saxe focuses on the role of microbiota in pain and how concomitant conditions in patients are often nutritionally linked.

Dr. Saxe discusses the role of nutrition in determining levels of inflammation and its potential in treating patients.

Dr. Marienfield discusses stigma as a major barrier in addiction treatment, as well as determining success based on patient goal.

Dr. Marienfield discusses therapy options for substance abuse patients in recovery.

The treatment controls blood sugar levels after meals in adults with type 1 and type 2 diabetes.

The study notes the importance of follow-up monitoring of sleep apnea in patients with IH.

Data show patients expected moderate improvements across all PCOQ domains with a median improvement range of 45% - 53.7%.

Investigators believe benefit of COVID-19 vaccination outweigh the risk of myocarditis in adolescent population.

Data show moderate net benefit for screening at 24 weeks of gestation or after, but there is insufficient evidence to assess benefit of screening before 24 weeks.

In an analysis, low GI/GL dietary patterns resulted in a reduction in HbA1c, compared with control diets with a mean difference of −0.31.

Data show 82% of studies reported significant abstinence from psychomotor stimulant use at the end-of-treatment assessment.

Data show the change in 24-hour ambulatory systolic blood pressure was significant between treatment and control groups with a reduction of 7.1 mm Hg.

Data show prevalence of pain increased with age in all age groups, while it was lower among men and non-Hispanic Asian adults.

Data show skeletal muscle relaxant associated with increased risk of fall-related injury (OR 1.28) and all-cause hospitalization (OR 1.11).

Kelly Chin, MD discusses the recent FDA approval of selexipag IV and breakthroughs in the cardiovascular care space.

Data show the expression levels of miR-214, BNP, NT-proBNP, and sST2 were significantly higher compared to the control group.

The app will deliver up-to-the-minute glucose data in patients using Freestyle Libre 2 glucose sensors.

Black patients received different opioid prescriptions compared to White patients, even after clinicians were given additional patient-level data.

The FDA noted the extent of the treatment effect of tenapanor is of unclear clinical significance, despite evidence of efficacy.

Higher microbiome α diversity had an association with less T2D and lower insulin resistance in individuals without diabetes.

Data show no clinically meaningful difference between insulin glargine-yfgn and insulin glargine in matters of safety, purity and potency.